BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 18829698)

  • 1. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration.
    Knopman DS; Kramer JH; Boeve BF; Caselli RJ; Graff-Radford NR; Mendez MF; Miller BL; Mercaldo N
    Brain; 2008 Nov; 131(Pt 11):2957-68. PubMed ID: 18829698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B; Agosti C; Premi E; Cerini C; Cosseddu M; Paghera B; Bellelli G; Padovani A
    Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year.
    Knopman DS; Jack CR; Kramer JH; Boeve BF; Caselli RJ; Graff-Radford NR; Mendez MF; Miller BL; Mercaldo ND
    Neurology; 2009 May; 72(21):1843-9. PubMed ID: 19470967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.
    Gordon E; Rohrer JD; Kim LG; Omar R; Rossor MN; Fox NC; Warren JD
    Neurology; 2010 Feb; 74(8):666-73. PubMed ID: 20177120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study.
    Cosseddu M; Benussi A; Gazzina S; Alberici A; Dell'Era V; Manes M; Cristillo V; Borroni B; Padovani A
    Eur J Neurol; 2020 Feb; 27(2):265-272. PubMed ID: 31448481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis.
    Libon DJ; Xie SX; Wang X; Massimo L; Moore P; Vesely L; Khan A; Chatterjee A; Coslett HB; Hurtig HI; Liang TW; Grossman M
    Neuropsychology; 2009 May; 23(3):337-46. PubMed ID: 19413447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration: demographic characteristics of 353 patients.
    Johnson JK; Diehl J; Mendez MF; Neuhaus J; Shapira JS; Forman M; Chute DJ; Roberson ED; Pace-Savitsky C; Neumann M; Chow TW; Rosen HJ; Forstl H; Kurz A; Miller BL
    Arch Neurol; 2005 Jun; 62(6):925-30. PubMed ID: 15956163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum.
    Premi E; Gualeni V; Costa P; Cosseddu M; Gasparotti R; Padovani A; Borroni B
    J Alzheimers Dis; 2016 Apr; 52(4):1227-35. PubMed ID: 27104906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study.
    Paolillo EW; Casaletto KB; Clark AL; Taylor JC; Heuer HW; Wise AB; Dhanam S; Sanderson-Cimino M; Saloner R; Kramer JH; Kornak J; Kremers W; Forsberg L; Appleby B; Bayram E; Bozoki A; Brushaber D; Darby RR; Day GS; Dickerson BC; Domoto-Reilly K; Elahi F; Fields JA; Ghoshal N; Graff-Radford N; G H Hall M; Honig LS; Huey ED; Lapid MI; Litvan I; Mackenzie IR; Masdeu JC; Mendez MF; Mester C; Miyagawa T; Naasan G; Pascual B; Pressman P; Ramos EM; Rankin KP; Rexach J; Rojas JC; VandeVrede L; Wong B; Wszolek ZK; Boeve BF; Rosen HJ; Boxer AL; Staffaroni AM;
    JMIR Aging; 2024 Jun; 7():e52831. PubMed ID: 38922667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
    Staffaroni AM; Bajorek L; Casaletto KB; Cobigo Y; Goh SM; Wolf A; Heuer HW; Elahi FM; Ljubenkov PA; Dever R; Kornak J; Appleby B; Bove J; Bordelon Y; Brannelly P; Brushaber D; Caso C; Coppola G; Dheel C; Dickerson BC; Dickinson S; Dominguez S; Domoto-Reilly K; Faber K; Ferrall J; Fields JA; Fishman A; Fong J; Foroud T; Forsberg LK; Gavrilova R; Gearhart D; Ghazanfari B; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford N; Grant I; Grossman M; Haley D; Hsiung GY; Huey ED; Irwin DJ; Jones DT; Jones L; Kantarci K; Karydas A; Kaufer DI; Kerwin DR; Knopman DS; Kraft R; Kremers WK; Kukull WA; Litvan I; Lucente D; Lungu C; Mackenzie IR; Maldonado M; Manoochehri M; McGinnis SM; McKinley E; Mendez MF; Miller BL; Multani N; Onyike C; Padmanabhan J; Pantelyat A; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Roberson ED; Rogalski E; Sengdy P; Shaw LM; Syrjanen J; Tartaglia MC; Tatton N; Taylor J; Toga A; Trojanowski JQ; Weintraub S; Wang P; Wong B; Wszolek Z; Boxer AL; Boeve BF; Kramer JH; Rosen HJ;
    Alzheimers Dement; 2020 Jan; 16(1):11-21. PubMed ID: 31914230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive nonfluent aphasia: a rare clinical subtype of FTLD-TDP in Japan.
    Aoki N; Tsuchiya K; Kobayashi Z; Arai T; Togo T; Miyazaki H; Kondo H; Ishizu H; Uchikado H; Katsuse O; Hirayasu Y; Akiyama H
    Neuropathology; 2012 Jun; 32(3):272-9. PubMed ID: 21978320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients.
    Maiovis P; Ioannidis P; Gerasimou G; Gotzamani-Psarrakou A; Karacostas D
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):26-30. PubMed ID: 27417072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan.
    Taomoto D; Sato S; Kanemoto H; Suzuki M; Hirakawa N; Takasaki A; Akimoto M; Satake Y; Koizumi F; Yoshiyama K; Takahashi R; Shigenobu K; Hashimoto M; Miyagawa T; Boeve B; Knopman D; Mori E; Ikeda M
    Psychogeriatrics; 2024 Mar; 24(2):281-294. PubMed ID: 38152057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we comparing frontotemporal dementia and Alzheimer disease patients with the right measures?
    Deutsch MB; Liang LJ; Jimenez EE; Mather MJ; Mendez MF
    Int Psychogeriatr; 2016 Sep; 28(9):1481-5. PubMed ID: 27079571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variety in the presentation of frontotemporal lobar degeneration.
    Shinagawa S
    Int Rev Psychiatry; 2013 Apr; 25(2):138-44. PubMed ID: 23611344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic criteria for fronto-temporal lobe degeneration].
    Robert PH; Lafont V; Snowden JS; Lebert F
    Encephale; 1999; 25(6):612-21. PubMed ID: 10668605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.